Monoclonal antibodies are infusion-based therapies used to treat COVID-19 infections. They are being used under Emergency Use Authorization by the FDA.
鈥淲e designed antibodies that we can infuse into someone鈥檚 blood, and instantaneously there are now antibodies,鈥� said David Wohl, MD, professor of medicine in the division of infectious diseases, explaining to CBS17 what the treatments entail.
The North Carolina Department of Health and Human Services reported for the week of June 23, just 100 courses of monoclonal antibodies were administered. For the week Aug. 18, that went up to a total of 3,018 courses administered statewide.
.